API Product   :    Doxorubicin
CEP   :    ¤
WCC   :    -
Therapeutic Use    :    Anticancer
Originator   :    Tokyo Womens Medical University
Tokyo Womens Medical University
CAS No.    :    23214-92-8
Trade Name.   :    ADRIAMYCIN
Molecular Weight   :    543.53 g/ mol
543.53 g/ mol
Molecular Formula   :    C27H29NO11
Doxorubicin is used to treat many types of cancer, including cancers of the blood (e.g., leukemia), bone, breast, ovaries, testicles, thyroid, head and neck, bladder, stomach and soft tissues, Hodgkin's disease, lung cancer, non-Hodgkin's lymphoma, Wilm's tumour, and neuroblastomas.
Doxorubicin, sold under the trade names Adriamycin among others, is a chemotherapy medication used to treat cancer. This includes breast cancer, bladder cancer, Kaposi's sarcoma, lymphoma, and acute lymphocytic leukemia. It is often used together with other chemotherapy agents. Doxorubicin is given by injection into a vein. Common side effects include hair loss, bone marrow suppression, vomiting, rash, and inflammation of the mouth. Other serious side effects may include allergic reactions such as anaphylaxis, heart damage, tissue damage at the site of injection, radiation recall, and treatment-related leukemia. People often experience red discoloration of the urine for a few days. Doxorubicin is in the anthracycline and antitumor antibiotic family of medications. It works in part by interfering with the function of DNA.